#153422

H357 Cell Line

Cat. #153422

H357 Cell Line

Cat. #: 153422

Unit size: 1x10^6 cells / vial

Tissue: Tongue

Disease: Cancer

Model: Tumourigenic cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Stephen Prime

Institute: University of Bristol

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: H357 Cell Line
  • Alternate name: H-357; h357
  • Research fields: Cancer
  • Tissue: Tongue
  • Disease: Cancer
  • Growth properties: Adherent
  • Model: Tumourigenic cell line
  • Conditional: Yes
  • Description: H357 was established from a squamous cell carcinoma (SCC) of the tongue (20mm) of a 74 year-old male patient. H357 has the following features: polygonal morphology, STNMP stage I, well differentiated and node negative tumour. This cell line has mutant p53, codon 110 exon 4, G to A; the previously reported mutant Ha-ras status of this cell line: codon: 13, G to A, codon 61, A-G is under investigation. H357 is highly responsive to TGF beta and undergoes epithelial to mesenchymal transition. H357 cells are tumourigenic in athymic nude mice on subcutaneous injection and non-tumourigenic on orthotopic injection. Haplotype information: A*02,A*31; B*40,B*44; Cw*03,Cw*05. Explore more human oral SCC cell lines from the same inventor including: H157, H376, H400, H314 and H103.
  • Cellosaurus id: CVCL_2462

Target Details

  • Target: Human oral squamous cell carcinoma, tongue

Handling

  • Format: Frozen
  • Growth medium: Split sub-confluent cultures (70-80%), approximately every 5-6 days, 1:8 to 1:10 using 0.25% trypsin/EDTA; 5% CO2; 37°C. Suggested seeding density 5 x 1000 cells/cm2. Cells can take approximately 10 minutes to detach, an alternative is to trypsinise 2 to 3 times with fresh trypsin for shorter periods for each trypsin application. Avoid knocking flasks during the trypsinisation process as this can lead to loss of viability. DMEM:HAMS F12 (1:1) + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) + 0.5 ug/ml sodium hydrocortisone succinate.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

References

  • Fahey et al. 1996. Br J Cancer. 74(7):1074-80. PMID: 8855977.
  • Yeudall et al. 1995. Eur J Cancer B Oral Oncol. 31(2):136-143. PMID: 7633286.
  • Prime et al. 1994. Int J Cancer. 56(3):406-412. PMID: 7508893.
  • Prime et al. 1994. Br J Cancer. 69(1):8-15. PMID: 8286215.
  • Yeudall et al. 1993. Eur J Cancer B Oral Oncol. 29B(1):63-67. PMID: 8180579.
  • Prime et al. 1990. J Pathol. 160(3):259-269. PMID: 1692339.